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What is new?
In this paper we investigated the lifespan of DDD pacemaker recipients who were inhabitants of Malopolska Province. We performed a trend analysis of age at implantation, survival after implantation and age at death between 1999 and 2015. Furthermore, we evaluated premature mortality measured with years of life lost method over a 17-year period. The results demonstrated continuous improvement in the survival after DDD pacemaker implantation and significant reduction of years of life lost. To our knowledge, it is the first report adopting an accurate and comprehensive measure which quantifies the level and trend of premature mortality in patients with permanent pacemaker.
Abstract:
Background: Pacemakers have become the standard of care for patients with severe bradycardia and conduction abnormalities. The survival prolongation and premature mortality can be assessed using Years of Life Lost (YLL). Results: Among a total of 3932 consecutive patients implanted with DDD pacemaker 1211 patients met study inclusion criteria. We noted an increase in mean age at implant from 70 in 1999 to 75.5 in 2015 (AAPC 0.6%; p < 0.05), the number of years lived after DDD pacemaker implantation from 2.6 years to 8.2 years (AAPC 7.4%; p < 0.05) and the mean age at death from 72.6 to 83.8 (AAPC 0.89%; p < 0.05). Finally, we observed the reduction of YLL per death from 17.4 in 1999 to 9 years in 2015 (AAPC -4%; p < 0.05). All trends were significant for both men and women.
Aims

Conclusions:
In the 17-year-long period we showed statistically significant changes in analysed trends, in particular a reduction in years of life lost per death.
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As shown in the FOLLOWPACE study published by Udo et al. pacemakers implanted for slow heart rhythm restore life expectancy to normal levels. [1] The results have suggested that the prognosis of contemporary pacemaker patient was primarily determined by concomitant cardiovascular disease, and not by the rhythm disorder itself. Therefore, after pacemaker implantation for bradycardia, more attention should be paid to the detection and treatment of other concurrent cardiovascular conditions. Noteworthy, in the previous study we showed that compared to the general population the observed survival of dual-chamber (DDD) pacemaker recipients was significantly inferior until 12 years post implant, whilst after 12 years of follow-up the observed survival was significantly superior. [2] Death rates alone do not provide a complete picture of the burden that deaths impose on the population. annual percentage change (AAPC) as a summary measure of trend that applies over an entire time period, and their 95% confidence intervals. When the trend is constant over the entire period of the interest the AAPC will be equal to the estimated APC. [5] In all analyses, p < 0.05 was considered statistically significant. Figure 2 ). Furthermore, the mean age at the time of death was increasing at the rate of 0.9% (95% CI, 0.7% to 1%; p < 0.05); 0.6% (95% CI, 0.4% to 0.8%; p < 0.05) for women and 1% (95% CI, 0.6% to 1%; p < 0.05) for men. The mean age of deceased pacemaker recipients in 1999 was 72.6 (in women 77.6 and in men 71.2), whereas in 2015 it was 83.8 (in women 84 and in men 83.5) (Figure 3 ). Finally, we observed the decrease of YLL per death with AAPC of -4% (95% CI, -4.9% to -3.1%; p < 0.05); -2.9% (95% CI, -3.9% to -2%; p < 0.05) for women and -4.2% (95% CI, -5.2% to -3.1%; p < 0.05) for men.
YLL per death in 1999 amounted to 17.4 (in women 13.3 and in men 18.6), whereas in 2015 YLL per death dropped to 9 (in women 8.8 and in men 9.2) (Figure 4 ).
Discussion
In this paper, we demonstrate trends in DDD pacemaker recipients' characteristics and outcomes among Malopolska Province patients in Poland across 17-year period from 1999 to 2015. We observed shifts toward DDD pacemaker implantation in older age, extended longevity after primary implant, and reduction in years of life lost per death. Furthermore, we noted that among men the APC of YLL reduction was greater than in women. Our findings provide robust evidence for trends in demographics and survival among large group of DDD pacemaker recipients.
Few studies have investigated the epidemiology of patients with dual-chamber pacing. Our previously presented findings demonstrated that women were older than men at the time of pacemaker implantation and showed the rise in average age at implant across the three decades. Similar trends have been observed in other countries [2, [8] [9] [10] [11] [12] [13] . In the present study we found that the average trend of increasing age at implantation in men exceeded the trend observed in women, which has not been previously reported. The significantly extending life expectancy of pacemaker recipients being implanted in the consecutive decades was shown by Brunner et al. [9] On the contrary, Bradshaw et al. concluded that era of implantation was not an independent predictor of mortality after adjustment for age. 
Study limitations
Our findings should be interpreted in the context of limitations imposed by a retrospective study design. Due to the lack of cause for death we were unable to perform comparisons with general population. Moreover, the results cannot be generalised for general pacemaker population as our sample consisted of only DDD pacemaker recipients. In addition, the present study population consisted of patients who deceased and were inhabitants of Malopolska Province at the last follow-up and excluded patients who remained alive until 2015 or were inhabitants of other provinces. On the other hand, the life expectancy may vary across regions in Poland and therefore by narrowing the sample we aimed to obtain the most accurate estimation of patients' demographics and lifespan. Nonetheless, we believe that the ability to generate locally representative estimates of demographic and survival trends in DDD pacemaker population is the strength of our study.
Conclusions:
In summary, we identified a shift toward favourable life expectancy and decrease in years of life lost among DDD recipients in Polish Malopolska Province. Many of the factors driving that positive trend include state-of-the-art cardiology care during follow-up but also national economic transformation, improvement in general health-care system and behavioural and lifestyle changes.
